Rigel Pharmaceuticals News

Rigel Pharmaceuticals | 8-K: Current report

Sep 19 16:06 ET

Rigel Pharmaceuticals | 8-K: Current report

Sep 3 08:31 ET

Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 6 17:04 ET

Rigel Pharmaceuticals | 8-K: Press Release, dated August 6, 2024, titled “Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update.”

Aug 6 16:15 ET

Rigel Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Aug 2 16:55 ET

Rigel Pharmaceuticals | 8-K: Current report

Jun 27 16:34 ET

Rigel Pharmaceuticals | 8-K: Current report

Jun 25 08:50 ET

Rigel Pharmaceuticals | 8-K: Current report

May 29 16:11 ET

Rigel Pharmaceuticals | 8-K: Rigel Reports First Quarter 2024 Financial Results and Provides Business Update

May 7 16:24 ET

Rigel Pharmaceuticals | 8-K: Current report

Apr 12 08:07 ET

Rigel Pharmaceuticals | DEFA14A: Others

Apr 10 16:53 ET

Rigel Pharmaceuticals | DEF 14A: Definitive information statements

Apr 10 16:53 ET

Rigel Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 29 17:08 ET

Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 5 16:18 ET

Rigel Pharmaceuticals | 8-K: Current report

Feb 22 08:01 ET

Rigel Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Rigel Pharmaceuticals | 8-K: Current report

Nov 30, 2023 06:04 ET

Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 7, 2023 16:16 ET

Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 1, 2023 16:31 ET

Rigel Pharmaceuticals | 8-K: Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 1, 2023 16:15 ET